Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are six articles published by Becker's Hospital Review this week, detailing Medtronic's supply chain disruptions from a week-long computer outage, the Food and Drug Administration's initiative to boost generic drug competition and more.
The Food and Drug Administration on Thursday approved Scibase's skin cancer detection device Nevisense.
The Food and Drug Administration on Thursday shared a strategic plan to completely eliminate the agency's backlog of orphan drug designation requests.
New York City-based New York Blood Center on June 25 declared an emergency blood shortage after supplies fell below the required minimums, reports Poughkeepsie Journal.
The following drug companies made headlines this past week.
United Parcel Service will freeze 70,000 employees' pension plans and switch to a new benefit system due to increasing costs and unpredictable future payments, reports Bloomberg.
The Dutch healthcare technology company Philips will purchase Colorado Springs, Colo.-based The Spectranetics Corp. for about $2.16 billion, reports Denver Business Journal.
The Food and Drug Administration on Tuesday published a list of more than 200 brand name drugs without generic alternatives on the market. While the list leaves many drugmakers susceptible to more generic competition, Valeant Pharmaceuticals is poised to be…
Congressman Chris Collins, R-N.Y., lost nearly $17 million after stock for an Australian drug company he'd heavily invested dropped by more than 90 percent on June 27, reports The Hill.
The Securities and Exchange Commission on Tuesday charged three individuals linked to Ariad Pharmaceuticals with insider trading, reports The Boston Globe.